BioPharma-Synergy (23-24 February 2021) is designed in the spirit of the traditional PharmaSynergy events catering to Business Development & Licensing executives. With the audience coming from Europe, LATAM, APAC, MENA & North America BioPharmaSynergy invites biosimilar-focused companies for two days of business partnering meetings and content-driven programme.
Discussions and presentations
The 2021 content-driven programme will focus on successful commercial strategies, pricing consideration, facilitating partnering across Geos between producers and buyers. Among the topics:
Global Biosimilars outlook; key players and their market access strategies
Regulatory approvals, tenders and pricing trends in Europe
Opportunities and trends in biosimilars by region: APAC, MENA, CIS, LATAM
Strategic considerations for biosimilar commercialisation – manufacturers’ point of view
In-licensing strategies in Europe and beyond